Inoviv
banner
inoviv.bsky.social
Inoviv
@inoviv.bsky.social
Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
inoviv.com
What a week at the #ADPD2025 conference in Vienna!

A key takeaway? There’s growing momentum around novel #biomarker discovery and using targeted #proteomics to develop fit-for-purpose assays — from AD and PD to ALS and beyond.

If we missed you at the booth, let’s fix that! hubs.la/Q03gNJFz0
April 10, 2025 at 3:48 PM
MasterKey™ v1.3 is here — now with 500+ new CNS-relevant proteins added to our 3,000+ protein catalog. From AD to ALS, build high-precision multiplexed assays for #neurological disease research and clinical trial support.

Explore the update - inoviv.com/masterkey/

#proteomics #biomarkers
April 3, 2025 at 4:24 PM
We're live at the #ADPD2025 Conference in Vienna!

Visit Inoviv at booth #82 to discuss key tactics for developing fit-for-purpose proteomic assays in neurological drug development.

We look forward to speaking with you! hubs.la/Q03fyQYf0
April 2, 2025 at 3:15 PM